Pharmacodynamic effects of a new fixed-dose clopidogrel–aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial

Pharmacodynamic effects of a new fixed-dose clopidogrel–aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial

Dual antiplatelet therapy (DAPT) with clopidogrel and aspirin is a widely prescribed regimen to prevent ischemic events in patients undergoing percutaneous coronary intervention (PCI). A fixed-dose combination (FDC) capsule (HCP0911) has been developed to provide dosing convenience and improve adher...

Full description

Bibliographic Details
Main Authors: Jin-Sin Koh, Yongwhi Park, Udaya S. Tantry, Jong-Hwa Ahn, Min Gyu Kang, Kyehwan Kim, Jeong Yoon Jang, Hyun Woong Park, Jeong Rang Park, Seok-Jae Hwang, Choong Hwan Kwak, Jin-Yong Hwang, Paul A. Gurbel, Young-Hoon Jeong
Format: Article
Language:English
Published: Taylor & Francis Group 2017-02-01
Series:Platelets
Subjects:
aspirin
aggregation
clopidogrel
platelet
Online Access:http://dx.doi.org/10.1080/09537104.2016.1206197

Internet

http://dx.doi.org/10.1080/09537104.2016.1206197

Similar Items